Publication | Open Access
SARS-CoV-2 Spike and Neutralizing Antibody Kinetics 90 Days after Three Doses of BNT162b2 mRNA COVID-19 Vaccine in Singapore
25
Citations
22
References
2022
Year
Both S-Ab and N-Ab show a good response following post-booster vaccination, with half-lives that may provide a prolonged antibody response.
| Year | Citations | |
|---|---|---|
Page 1
Page 1